NL-OMON50706
Recruiting
Not Applicable
A multicenter study for validation of biomarkers and observational study for immune regulatory mechanisms in Juvenile Dermatomyositis - Biomarkers and immunoregulatory mechanisms in JDM
niversitair Medisch Centrum Utrecht0 sites365 target enrollmentTBD
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- juvenile dermatomyositis
- Sponsor
- niversitair Medisch Centrum Utrecht
- Enrollment
- 365
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •\- consenting to participate
- •\- diagnosis of JDM according to Bohan and Peter criteria and/or EULAR/ACR
- •classification criteria.
- •\- age \< 18 years
- •S4S disease controls:
- •\- consenting to participate
- •\- age \< 18 years
- •\- diagnosis of congenital myopathy, muscular dystrophy or mitochondrial
- •myopathy or other non\-inflammatory myopathies or neuromuscular diseases
- •\- Consenting to participate
Exclusion Criteria
- •In all groups: no informed consent
- •S4S disease controls: chronic inflammatory diseases
- •Healthy controls: immune\-mediated, neurological or metabolic diseases
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
A Multicenter Study on Biomarker Development Utilizing AI Multiomics for Patients with Advanced Solid Malignant TumorsAdvanced Solid MalignanciesJPRN-UMIN000043899ational Cancer Center Hospital East2,768
Recruiting
Not Applicable
A single arm multicenter biomarker study determining the response to taxane-based chemotherapy in metastatic breast cancer patients with ESR1 mutations in cellfree DNAbreast cancer, metastasis, ESR1 mutations, chemotherapyNL-OMON25511Erasmus MC Cancer Institute, department of Medical Oncology185
Recruiting
Not Applicable
A single arm multicenter biomarker study determining the response to taxane-based chemotherapy in metastatic breast cancer (MBC) patients with ESR1 mutations in cell-free DNA: TAX-ESR1 study.Metastasis of breast cancer10006291NL-OMON46354Erasmus MC, Universitair Medisch Centrum Rotterdam175
Completed
Not Applicable
Study on biomarkers for the effect and safety of the treatment with Atezolizumab + Bevacizumab for liver cancerunresectable advanced hepatocellular carcinomaJPRN-UMIN000047758agoya University Graduate School of Medicine99
Recruiting
Not Applicable
METBEIGE biomarker studycolorectal cancerJPRN-jRCT1080224637ational Cancer Center Hospital East54